AP2015008876A0 - Formulation comprising a hypolipidemic agent - Google Patents
Formulation comprising a hypolipidemic agentInfo
- Publication number
- AP2015008876A0 AP2015008876A0 AP2015008876A AP2015008876A AP2015008876A0 AP 2015008876 A0 AP2015008876 A0 AP 2015008876A0 AP 2015008876 A AP2015008876 A AP 2015008876A AP 2015008876 A AP2015008876 A AP 2015008876A AP 2015008876 A0 AP2015008876 A0 AP 2015008876A0
- Authority
- AP
- ARIPO
- Prior art keywords
- formulation
- hypolipidemic agent
- hypolipidemic
- agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2470MU2013 IN2013MU02470A (et) | 2013-07-25 | 2013-07-25 | |
| PCT/IN2014/000489 WO2015011730A1 (en) | 2013-07-25 | 2014-07-24 | Formulation comprising a hypolipidemic agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AP2015008876A0 true AP2015008876A0 (en) | 2015-11-30 |
Family
ID=51787141
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AP2015008876A AP2015008876A0 (en) | 2013-07-25 | 2015-07-24 | Formulation comprising a hypolipidemic agent |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US9610277B2 (et) |
| EP (1) | EP3024446A1 (et) |
| JP (1) | JP2016523895A (et) |
| KR (1) | KR101786843B1 (et) |
| CN (1) | CN105407873A (et) |
| AP (1) | AP2015008876A0 (et) |
| AR (1) | AR097067A1 (et) |
| AU (1) | AU2014294548B2 (et) |
| BR (1) | BR112015031878A2 (et) |
| CA (1) | CA2917923A1 (et) |
| EA (1) | EA201690072A1 (et) |
| HK (1) | HK1219222A1 (et) |
| IN (1) | IN2013MU02470A (et) |
| MA (1) | MA38865A1 (et) |
| MX (1) | MX2015016971A (et) |
| NZ (1) | NZ714558A (et) |
| PH (1) | PH12015502802A1 (et) |
| SG (1) | SG11201509798PA (et) |
| TW (1) | TW201545773A (et) |
| WO (1) | WO2015011730A1 (et) |
| ZA (1) | ZA201508682B (et) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101427486B (zh) | 2006-05-23 | 2013-06-19 | 英特尔公司 | 具有定向天线和一个或多个毫米波反射器的毫米波通信系统 |
| MY191100A (en) | 2011-01-31 | 2022-05-30 | Cadila Healthcare Ltd | Treatment for lipodystrophy |
| WO2014174524A1 (en) | 2013-04-22 | 2014-10-30 | Cadila Healthcare Limited | A novel composition for nonalcoholic fatty liver disease (nafld) |
| EP3004053B1 (en) | 2013-05-30 | 2021-03-24 | Cadila Healthcare Limited | A process for preparation of pyrroles having hypolipidemic hypocholesteremic activities |
| TW201513857A (zh) | 2013-07-05 | 2015-04-16 | Cadila Healthcare Ltd | 協同性組成物 |
| IN2013MU02470A (et) | 2013-07-25 | 2015-06-26 | Cadila Healthcare Ltd | |
| WO2015033357A2 (en) | 2013-09-06 | 2015-03-12 | Cadila Healthcare Limited | An improved process for the preparation of pyrrole derivatives |
| WO2017064635A2 (en) | 2015-10-14 | 2017-04-20 | Cadila Healthcare Limited | Pyrrole compound, compositions and process for preparation thereof |
| KR101913830B1 (ko) * | 2016-12-05 | 2018-10-31 | 주식회사 코쿤디자인 | 기능성 led 어셈블리를 이용한 디스플레이 장치 |
| JP6840853B2 (ja) | 2016-12-09 | 2021-03-10 | カディラ・ヘルスケア・リミテッド | 原発性胆汁性胆管炎の治療 |
| EP3923932A4 (en) * | 2019-02-13 | 2022-11-16 | Cadila Healthcare Limited | TREATMENT OF POLYCYSTIC OVARY SYNDROME (PCOS) |
| US20220169603A1 (en) * | 2019-03-11 | 2022-06-02 | Cadila Healthcare Ltd. | Novel salts, crystalline forms and premix of hypolipidemic agent |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4231938A (en) | 1979-06-15 | 1980-11-04 | Merck & Co., Inc. | Hypocholesteremic fermentation products and process of preparation |
| US4444784A (en) | 1980-08-05 | 1984-04-24 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
| MX7065E (es) | 1980-06-06 | 1987-04-10 | Sankyo Co | Un procedimiento microbiologico para preparar derivados de ml-236b |
| US5354772A (en) | 1982-11-22 | 1994-10-11 | Sandoz Pharm. Corp. | Indole analogs of mevalonolactone and derivatives thereof |
| US5030447A (en) * | 1988-03-31 | 1991-07-09 | E. R. Squibb & Sons, Inc. | Pharmaceutical compositions having good stability |
| FI94339C (fi) | 1989-07-21 | 1995-08-25 | Warner Lambert Co | Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi |
| US5089514A (en) | 1990-06-14 | 1992-02-18 | Pfizer Inc. | 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents |
| RU2134686C1 (ru) | 1992-07-03 | 1999-08-20 | Смитклайн Бичам П.Л.С. | Гетероциклическое соединение, или его таутомерная форма, и/или фармацевтически приемлемая соль, и/или фармацевтически приемлемый сольват, фармацевтическая композиция, снижающая содержание глюкозы в крови, способ лечения и/или профилактики гипергликемии |
| GB9225386D0 (en) | 1992-12-04 | 1993-01-27 | Smithkline Beecham Plc | Novel compounds |
| US5387613A (en) | 1993-07-23 | 1995-02-07 | Ribogene, Inc. | Treatment of tachyarrhythmias of supraventricular origin |
| GB9326171D0 (en) | 1993-12-22 | 1994-02-23 | Smithkline Beecham Plc | Novel compounds |
| WO1996004261A1 (en) | 1994-07-29 | 1996-02-15 | Smithkline Beecham Plc | Benzoxazoles and pryridine derivatives useful in the treatment of the type ii diabetes |
| ES2164241T3 (es) | 1995-04-28 | 2002-02-16 | Daiichi Seiyaku Co | Compuestos pentaciclicos. |
| GB9600464D0 (en) | 1996-01-09 | 1996-03-13 | Smithkline Beecham Plc | Novel method |
| GB9606805D0 (en) | 1996-03-30 | 1996-06-05 | Glaxo Wellcome Inc | Medicaments |
| CN1280574A (zh) | 1997-10-27 | 2001-01-17 | 雷迪研究基金会 | 新的杂环化合物及其在医药中的应用、它们的制备方法和含有它们的药物组合物 |
| WO1999019313A1 (en) | 1997-10-27 | 1999-04-22 | Dr. Reddy's Research Foundation | Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them |
| AU1120599A (en) | 1998-04-23 | 1999-03-08 | Dr. Reddy's Research Foundation | New heterocyclic compounds and their use in medicine, process for their reparation and pharmaceutical compositions containing them |
| NZ504106A (en) | 1998-05-27 | 2003-02-28 | Dr | Fused Oxazine, Thiazine and pipyridine compounds, process for their preparation and pharmaceutical compositions containing them |
| JP2002527503A (ja) | 1998-10-21 | 2002-08-27 | ノボ ノルディスク アクティーゼルスカブ | 新規化合物類、それらの調製及び使用 |
| WO2000023451A1 (en) | 1998-10-21 | 2000-04-27 | Novo Nordisk A/S | New compounds, their preparation and use |
| EP1123292A1 (en) | 1998-10-21 | 2001-08-16 | Novo Nordisk A/S | New compounds, their preparation and use |
| CO5150173A1 (es) | 1998-12-10 | 2002-04-29 | Novartis Ag | Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv |
| NZ520402A (en) | 2000-01-19 | 2006-04-28 | Cadila Healthcare Ltd | Novel compounds having hypolipedemic, hypocholesteremic activites, process for their preparation and pharmaceutical compositions containing them |
| US6395767B2 (en) | 2000-03-10 | 2002-05-28 | Bristol-Myers Squibb Company | Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
| WO2002024625A2 (en) | 2000-09-22 | 2002-03-28 | Dr. Reddy's Research Foundation | Process for the preparation of 3-aryl-2-hydroxy propanoic acid derivatives |
| UA74912C2 (en) | 2001-07-06 | 2006-02-15 | Merck & Co Inc | Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes |
| US6987123B2 (en) | 2001-07-26 | 2006-01-17 | Cadila Healthcare Limited | Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| US7407955B2 (en) | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
| JP4745616B2 (ja) * | 2003-02-26 | 2011-08-10 | 武田薬品工業株式会社 | 安定化されたイミダゾール誘導体含有医薬組成物、イミダゾール誘導体の安定化方法 |
| WO2005031335A1 (ja) | 2003-09-26 | 2005-04-07 | Mitsubishi Rayon Co., Ltd. | 電気泳動装置および電気泳動法並びにそれを用いた生体関連物質の検出方法 |
| CN102127053A (zh) | 2004-03-15 | 2011-07-20 | 武田药品工业株式会社 | 二肽基肽酶抑制剂 |
| DE602007009489D1 (de) * | 2006-02-22 | 2010-11-11 | Eisai R&D Man Co Ltd | Stabilisierte pharmazeutische zusammensetzung |
| WO2007122635A2 (en) | 2006-04-26 | 2007-11-01 | Astron Research Limited | Controlled release formulation comprising anti-epileptic drugs |
| JP5424571B2 (ja) * | 2007-04-12 | 2014-02-26 | 協和発酵キリン株式会社 | トピラマート含有固形製剤 |
| PT2641596T (pt) | 2009-11-26 | 2018-07-31 | Genfit | Utilização de derivados de 1,3-difenilprop-2-en-1-ona para tratamento de doenças hepáticas |
| BR112013008985A2 (pt) * | 2010-10-12 | 2016-07-05 | Cerecor Inc | composições antitussígenas compreendendo memantina |
| MY191100A (en) | 2011-01-31 | 2022-05-30 | Cadila Healthcare Ltd | Treatment for lipodystrophy |
| WO2014174524A1 (en) * | 2013-04-22 | 2014-10-30 | Cadila Healthcare Limited | A novel composition for nonalcoholic fatty liver disease (nafld) |
| EP3004053B1 (en) | 2013-05-30 | 2021-03-24 | Cadila Healthcare Limited | A process for preparation of pyrroles having hypolipidemic hypocholesteremic activities |
| TW201513857A (zh) | 2013-07-05 | 2015-04-16 | Cadila Healthcare Ltd | 協同性組成物 |
| IN2013MU02470A (et) | 2013-07-25 | 2015-06-26 | Cadila Healthcare Ltd | |
| US9951009B2 (en) | 2013-08-29 | 2018-04-24 | Cadila Healthcare Limited | Polymorphic form of pyrrole derivative and intermediate thereof |
| WO2015033357A2 (en) | 2013-09-06 | 2015-03-12 | Cadila Healthcare Limited | An improved process for the preparation of pyrrole derivatives |
-
2013
- 2013-07-25 IN IN2470MU2013 patent/IN2013MU02470A/en unknown
-
2014
- 2014-07-24 NZ NZ714558A patent/NZ714558A/en not_active IP Right Cessation
- 2014-07-24 AU AU2014294548A patent/AU2014294548B2/en not_active Expired - Fee Related
- 2014-07-24 SG SG11201509798PA patent/SG11201509798PA/en unknown
- 2014-07-24 JP JP2016522969A patent/JP2016523895A/ja active Pending
- 2014-07-24 BR BR112015031878A patent/BR112015031878A2/pt not_active IP Right Cessation
- 2014-07-24 TW TW103125304A patent/TW201545773A/zh unknown
- 2014-07-24 MA MA38865A patent/MA38865A1/fr unknown
- 2014-07-24 WO PCT/IN2014/000489 patent/WO2015011730A1/en active Application Filing
- 2014-07-24 CN CN201480041453.7A patent/CN105407873A/zh active Pending
- 2014-07-24 KR KR1020157036380A patent/KR101786843B1/ko active IP Right Grant
- 2014-07-24 EA EA201690072A patent/EA201690072A1/ru unknown
- 2014-07-24 US US14/899,912 patent/US9610277B2/en active Active
- 2014-07-24 CA CA2917923A patent/CA2917923A1/en not_active Abandoned
- 2014-07-24 EP EP14787059.6A patent/EP3024446A1/en not_active Withdrawn
- 2014-07-24 MX MX2015016971A patent/MX2015016971A/es active IP Right Grant
- 2014-07-25 AR ARP140102777A patent/AR097067A1/es unknown
-
2015
- 2015-07-24 AP AP2015008876A patent/AP2015008876A0/xx unknown
- 2015-11-25 ZA ZA2015/08682A patent/ZA201508682B/en unknown
- 2015-12-17 PH PH12015502802A patent/PH12015502802A1/en unknown
-
2016
- 2016-06-21 HK HK16107193.2A patent/HK1219222A1/zh unknown
-
2017
- 2017-03-31 US US15/475,812 patent/US10098868B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| TW201545773A (zh) | 2015-12-16 |
| AU2014294548B2 (en) | 2017-08-10 |
| IN2013MU02470A (et) | 2015-06-26 |
| US20160136131A1 (en) | 2016-05-19 |
| KR101786843B1 (ko) | 2017-10-18 |
| MX2015016971A (es) | 2016-04-25 |
| JP2016523895A (ja) | 2016-08-12 |
| KR20160013150A (ko) | 2016-02-03 |
| US9610277B2 (en) | 2017-04-04 |
| SG11201509798PA (en) | 2016-02-26 |
| US20170266158A1 (en) | 2017-09-21 |
| AU2014294548A1 (en) | 2015-12-17 |
| CA2917923A1 (en) | 2015-01-29 |
| EA201690072A1 (ru) | 2016-06-30 |
| CN105407873A (zh) | 2016-03-16 |
| EP3024446A1 (en) | 2016-06-01 |
| US10098868B2 (en) | 2018-10-16 |
| BR112015031878A2 (pt) | 2017-07-25 |
| ZA201508682B (en) | 2017-03-29 |
| AR097067A1 (es) | 2016-02-17 |
| NZ714558A (en) | 2017-02-24 |
| HK1219222A1 (zh) | 2017-03-31 |
| WO2015011730A1 (en) | 2015-01-29 |
| MA38865A1 (fr) | 2017-12-29 |
| PH12015502802A1 (en) | 2016-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1219222A1 (zh) | 包含降血脂藥的製劑 | |
| EP2956781A4 (en) | RECHARGE BLOCK | |
| GB201304784D0 (en) | Dispenser | |
| EP2968569A4 (en) | COUGAR FORMULATION | |
| GB201317990D0 (en) | A conncetor | |
| GB2510428B (en) | Glove dispenser | |
| GB201320432D0 (en) | Novel formulation | |
| EP2992813A4 (en) | LIQUID DETECTION INSTRUMENT | |
| GB2515360B (en) | Dispenser | |
| EP2952799A4 (en) | PIPE REINFORCING ELEMENT | |
| PT3060256T (pt) | Uma nova formulação estável | |
| EP2958828A4 (de) | Spender | |
| SG11201604752SA (en) | Antibacterial peptide-inducing agent | |
| GB201322948D0 (en) | Improved formulation | |
| GB2517232B (en) | Formulation | |
| ZA201505008B (en) | Cleaning agent | |
| HUE060750T2 (hu) | Fluorozó-szerek | |
| GB201317718D0 (en) | Novel formulation | |
| TWI563390B (en) | Completion packet return | |
| EP3037100A4 (en) | MEANS TO PREVENT MUSCLE ATROPHY | |
| HK1209981A1 (en) | Formulation | |
| GB201312347D0 (en) | Formulation | |
| GB201312761D0 (en) | A composition | |
| GB201313018D0 (en) | A Composition for anti-microbial use | |
| GB201306657D0 (en) | Trestle |